- Staat
- CA
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 04.08.2022
- Impfdatum
- 26.07.2022
- Beginn
- 26.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anxiety
Asthenia
Hyperhidrosis
Immediate post-injection reaction
Injection site pain
Memory impairment
Presyncope
Symptomtext
The patient was first given Gardasil 9 (dose #2) in the right deltoid. I then gave Tdap then Typhim Injectable in the left deltoid. Immediately after giving Typhim the patient had a vasovagal episode that listed about 1 minute. Afterwards the student was diaphoretic and briefly could not recall where he was. After 2 minutes the student was no longer diaphoretic and was alert and oriented x3. He was anxious but consolable. He was observed for 20minutes after the vasovagal event when he stated he "felt fine." At depart he was a/o x3 with a steady gait. On August 3rd 2022 the patient reported persistent left shoulder pain and described it as "debilitating."
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No illnesses reported by patient
- Vorgeschichte
- None
- Andere Medikamente
- No medications
- Allergien
- Amoxicillin - rash
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 21.12.2022
- Impfdatum
- 02.11.2022
- Beginn
- 02.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Dyspnoea
Erythema
Flushing
Pruritus
Urticaria
Symptomtext
Pt came into the clinic for a travel consult. Pt received Menveo, Typhoid, IPV(Polio), and Hepatitis A #1 vaccine. Post vaccination pt was instructed to wait in the lobby for 15 minutes. While the pt was in the lobby, 10 minutes post vaccine administration, pt c/o itching all over the body. Pt went up to receptionist to report symptoms. Receptionist informed RN to check on pt. Upon assessment, pt noted to be flushed, with redness in face and pt c/o itching all over, and visible hives noted on neck, arms, chest, clavicle area and back. Pt denied SOB or trouble breathing. Pt assisted to exam room, and alerted another RN, and MD for further assessment/evaluation. After a couple of minutes in exam room, pt stated, "something in my throat/itching", and RN noted hives spreading all over face and body. MD was notified, and in room, and Adult Epi Pen(0.3mg) administered IM. Vital Signs were taken, Code was called at the same time as Epi Pen was administered. 1 minute after Epi Pen was administered, pt stated that her throat sensation is improving. Pt also reported that her itching was improving. Code team arrived 2 minutes after Epi pen was administered. Ambulance was called at the same time. Pt was stable, and paramedics assisted pt to gurney and was transferred to ER via an ambulance for further evaluation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- See ER notes.
- Aktuelle Erkrankungen
- Essential HTN.
- Vorgeschichte
- Essential HTN.
- Andere Medikamente
- Amlodipine, ASA, Magnesium, Nystatin Cream, Kenalog cream.
- Allergien
- None at time of visit
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 28.09.2022
- Impfdatum
- 28.09.2022
- Beginn
- 28.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Altered state of consciousness
Blood glucose
Blood pressure abnormal
Dizziness
Hyperhidrosis
Nausea
Pallor
Posture abnormal
Tremor
Symptomtext
with in 30 seconds to 1min of administering both vaccines the patients head went back and had shook for about 10 to 15 seconds, patient came out of it and asked if he had been asleep. EMS was called. patient was pale sweatin and nausea as well and light headed. No problems breathing or rash. EMS advised to keep eye on patient until someone arrived.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- paramedics monitored vitals and blood glucose. was given a liter of saline and ondansetron. until blood pressure returned to normal
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 21.12.2023
- Impfdatum
- 28.08.2023
- Beginn
- 28.08.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anxiety
Chest discomfort
Dizziness
Dysphonia
Hypersensitivity
Incorrect route of product administration
Stridor
Wheezing
Symptomtext
Reported Symptoms: 10008493:CHEST TIGHTNESS OF; 10020200:HOARSE VOICE; 10042241:STRIDOR; 10047924:WHEEZING; Narrative: Unclear if allergic reaction vs. other. Taken to ED and treated as if allergic reaction. Yellow Fever vaccine was administered IM unintentionally rather than Subq; however, unclear if/ how this contributed. Other Relevant HX: Patient received vaccines before international travel. Received hepatitis A and typhoid vaccine then Yellow Fever vaccine 30-60 minutes later. Yellow Fever vaccine was unintentionally administered intramuscularly with a subcutaneous needle. Patient reported feeling whoozy and chest tightness -15 minutes after the vaccine and attributed it to anxiety. Patient then reported some hoarseness in throat so taken to ED. Emergency Department provider noted possible stridor vs. wheezing on physical exam. Diagnosis = allergic reaction phenomenon. Chest tightness resolved before intervention. Epinephrine, methylprednisolone, diphenhydramine, and famotidine administered. Patient discharged at baseline condition with 5 days of prednisone. Reported no issues one day after. Other: chest tightness, voice hoarsness, ?stridor vs. wheezing
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- CBC, BMP, BNP, and troponin all within normal limits. Vital signs within normal limits.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 65,0
- Geschlecht
- M
- Eingang
- 25.10.2023
- Impfdatum
- 23.08.2023
- Beginn
- 24.08.2023
- Tage bis Beginn
- 1,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dysphagia
Fatigue
Pharyngeal swelling
Pyrexia
Urticaria
X-ray normal
Symptomtext
Went home from receiving the immunization and was tired/exhausted (had been fine that day prior to immunization) and had a fever for 3 days. The day after he received the immunization he developed "hives" on the outside of his neck. 2 days after receiving the immunizations he had swelling on the inside of his throat, he could not swallow his spit or water and had trouble talking. He was able to breath but it was labored and he had to keep his head back and his chin up. This lasted for a few hours. They were ono vacation and not in a location that had medical care so they packed up and headed in to town. By the time they got to a place with medical care it was resolving.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- He went to an urgent care the next day and an xray of his neck was negative. They gave him some benadryl.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 11.05.2023
- Impfdatum
- 11.05.2023
- Beginn
- 11.05.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Allergy to vaccine
Flushing
Hypersensitivity
Pruritus
Throat clearing
Urticaria
Symptomtext
Approximately around 10:10am, patient was screen for contraindication, and stated that he had allergic reaction to Covid Bivalent vaccine. Patient stated that he had mild itchiness and broke out in hive. He was given Benadryl but unsure of the dosage. Other than allergic reaction to Covid 19 Bivalent vaccine (Moderna) patient has no known history of allergies. 10:20am, patient received typhoid vaccine to left deltoid 1mL. Given history to previous reaction to Covid 19, patient is aware that he will be kept for 15 minutes observation. Approximately, about 10:25 patient began scratching his head. LVN observed that the patient was clearing his throat and ask if he was alright. LVN also noted that the patient face was flush. Patient show no sign of difficulty breathing nor urticaria. 10:27 patient stated that he felt itchy and asked for Benadryl. Diphenhydramine 25mg capsule was given orally. 10:30am patient stated that he felt better and wanted to leave. However, LVN kept patient for another 10 minutes observation. 10:40 patient left the exam room ambulating independently, alert and oriented with no sign of distress.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- no
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- no
- Andere Medikamente
- NO
- Allergien
- no known allergies to foods or medications other than Covid 19 Bivalent vaccine (Moderna)
- Vorherige Impfungen
- Covid 19 Bivalent Moderna
- Staat
- TX
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 28.11.2022
- Impfdatum
- 18.11.2022
- Beginn
- 19.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Vaccination site erythema
Vaccination site pruritus
Vaccination site swelling
Symptomtext
Patient reported that Vaccine site became swollen red and itchy and was progressive daily until seen by practitioner and prescribed Benadryl ( OTC ) and Azithromycin Zpac
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination site pruritus
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Claritin D 12-hour tab po bid prn
- Allergien
- NKDA or food or pets
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 23.11.2022
- Impfdatum
- 22.11.2022
- Beginn
- 23.11.2022
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Urticaria
Symptomtext
Diffuse hive-like rash to extremities and body trunk
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- Adderall XR
- Allergien
- NKDA, No known material allergy
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 11.10.2022
- Impfdatum
- 08.09.2022
- Beginn
- 08.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Joint range of motion decreased
Symptomtext
Pt presented to clinic on 10/11/2022 for Twinrix #2. At this visit, pt reported feeling a "searing pain" in R shoulder during vaccine administration on 09/ 08/2022. Pt received four vaccines at visit on 09/08/2022 (Twinrix, flu, COVID-19 booster, and Typhoid). Twinrix and annual flu administered in pt's R deltoid. Pt unsure whether Twinrix or annual flu caused pain during administration; reports that he thinks it was Twinrix due to the volume injected. Pt reported feeling "normal soreness" for "about a week" after vaccination, then states feeling increased pain and decreased ROM in R shoulder. Pt reported following-up with PCMP. Per pt, PCMP advised pt to take ibuprofen PRN and apply warm compresses to affected site; pt denies improvement or resolution of sx with these interventions. Per pt, pain and decreased ROM in R shoulder have neither improved nor worsened since sx onsent.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- Unknown
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Unknown
- Andere Medikamente
- Per provider note: Magnesium oral capsule
- Allergien
- Per provider note: Sulfa abx
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 33,0
- Geschlecht
- M
- Eingang
- 23.08.2022
- Impfdatum
- 18.08.2022
- Beginn
- 01.08.2022
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Adverse reaction
Arthralgia
Burning sensation
Chills
Injection site pruritus
Injection site rash
Rectal haemorrhage
Urticaria
Vaccination site bruising
Vaccination site reaction
Symptomtext
Pt is a 33 y/o who present to clinic for adverse reaction around the Jynneos vaccine site. He received IXIARO and Typhoid vaccine on right arm and Jynneos vaccine on left arm in preparation for Travel. He notes that he received the Monkeypox vaccine on 8/18/22 and developed an itchy rash on the right arm on 8/19/22 around the area he received the Jynneos vaccine along with burning sensation and chills. He went to ED. He received Cefadroxil and he developed hives on arm and face about 3 hours after the first dose. He had a fever of 100.0F with joint aches, chills on 8/19/2022 and lasted about 3 days. Denied vomiting, diarrhea, coughing, SOB, or loss of smell concerning for Covid. He had one small speck of blood on toilet paper. Denies any other sick contacts. He took Benadryl last night for the reaction with the antibiotic. His hives resolved and had less itching where his monkeypox vaccine was. No symptoms noted on left arm. He note that he has a bruise around the area of the vaccination. Denies history of HIV, no diagnosis of eczema. Of note, he was diagnosed with COVID-19 on 22Jun22.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- diagnosed with COVID 19 on 22Jun22
- Vorgeschichte
- headaches; seasonal allergies
- Andere Medikamente
- maxalt; zyrtec PRn
- Allergien
- PCN
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 17.08.2022
- Impfdatum
- 05.08.2022
- Beginn
- 11.08.2022
- Tage bis Beginn
- 6,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Herpes zoster
Rash
Rash vesicular
Symptomtext
blistery rash that appeared on her left arm on 11 August after receiving the Typhoid and Meningitis vaccines on 05 August, diagnosed as shingles and treated with Valtrex
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Migraines
- Andere Medikamente
- Amitriptyline benzoyl peroxide topical rizatriptan tretinoin cream
- Allergien
- vancomycin
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 26.12.2023
- Impfdatum
- 01.12.2023
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
medication error due to administration of expired vaccine with no reported adverse event; Initial information received on 18-Dec-2023 regarding an unsolicited valid non-serious case received from a nurse. This case involves a 36 years old female patient who experienced medication error due to administration of expired typhoid VI polysaccharide vaccine [typhim VI] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE (HEPATITIS A VACCINE) for Prophylactic vaccination. On 01-Dec-2023, the patient received a 0.5 ml dose of suspect typhoid VI polysaccharide vaccine Solution for injection (lot U2A471M, expiry date: 02-NOV-2023 with unknown strength) via intramuscular route in the left deltoid as Immunization that was medication error due to administration of expired vaccine with no reported adverse event (expired product administered) (latency: same day). It was reported "the nurse who reported and the physician who gave the TYPHIM VI dose were not from the same hospital so nurse said that she cannot give more information in case there is a follow up. She gave the information of the physician documented in the patient's profile but she is not sure if it is the same physician who ordered for the administration." This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HEPATITIS A VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 08.12.2023
- Impfdatum
- 01.12.2023
- Beginn
- 01.12.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
administering an expired TYPHIM VI to a patient with no reported adverse event; Initial information received on 01-Dec-2023 regarding an unsolicited valid non-serious case received via other health professional. This case involves a 36-year-old female patient, administering an expired typhoid VI polysaccharide vaccine [Typhim VI] to a patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On 01-Dec-2023, the patient received 0.5 ml total dose of suspect typhoid VI polysaccharide vaccine, Solution for injection (strength: unknown) (lot: U2A471M, expiry date: 02-Nov-2023) via intramuscular route in the left deltoid for immunization and administering an expired typhim vi to a patient with no reported adverse event (expired product administered) (latency: same day). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive and Regulatory Authority Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 24.11.2023
- Impfdatum
- 13.11.2023
- Beginn
- 13.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
TYPHIM that expired on 02Nov2023 was administered on 13Nov2023/medication error/an inappropriate use due to expired vaccine administered with no reported adverse event; Initial information was received on 17-Nov-2023 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 44 years old female patient who received typhoid vi polysaccharide vaccine [Typhim Vi] that expired on 02nov2023 was administered on 13nov2023/medication error/an inappropriate use due to expired vaccine administered with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (TDAP) for Prophylactic vaccination; and meningococcal vaccine for Prophylactic vaccination. On 13-Nov-2023, the patient received a dose 1 of 0.5 ml of suspect typhoid vi polysaccharide vaccine (Solution for injection) (lot U2A471M , Expiry date : 02-Nov-2023, strength was unknown) via intramuscular route in the left deltoid for prophylactic vaccination (Immunization) and typhim that expired on 02nov2023 was administered on 13nov2023/medication error/an inappropriate use due to expired vaccine administered with no reported adverse event (expired product administered) (latency : same day). Action taken with typhoid vaccine (Typhim Vi) was not applicable. At time of reporting, the outcome was Unknown for the event typhim that expired on 02nov2023 was administered on 13nov2023/medication error/an inappropriate use due to expired vaccine administered with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- TDAP; MENINGOCOCCAL VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 6,0
- Geschlecht
- F
- Eingang
- 18.11.2023
- Impfdatum
- 06.11.2023
- Beginn
- 06.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
patient received an expired dose of TYPHIM VI with no reported adverse event; Initial information received on 07-Nov-2023 regarding an unsolicited valid non-serious case received from non-healthcare professional. This case involves a 6 years old female patient who received an expired dose of Typhoid VI Polysaccharide vaccine [TYPHIM VI] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Influenza vaccine (Influenza) for Prophylactic vaccination. On 06-Nov-2023, the patient received an expired 0.5 ml dose (strength: standard) of suspect Typhoid VI polysaccharide vaccine Solution for injection of lot U2A471M and expiry: 02-Nov-2023 via intramuscular route in the right deltoid for immunization; with no reported adverse event (expired product administered) (latency: same day). No lab data was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- INFLUENZA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 16.11.2023
- Impfdatum
- 06.11.2023
- Beginn
- 06.11.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
expired dose of Typhim VI was given to a patient (with no reported adverse event); Initial information received on 07-Nov-2023 regarding an unsolicited valid non-serious case received from other health professional. This case involves a 22-years-old female patient (Not pregnant) who was administered expired dose of typhoid VI polysaccharide vaccine [Typhim VI] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Yellow Fever Vaccine, and Rabies Vaccine for Prophylactic vaccination. On 06-Nov-2023, the patient received 0.5 mL expired dose of suspect typhoid VI polysaccharide vaccine (Frequency: once; Strength: Standard) (lot number: U2A471M; expiry date: 02-Nov-2023) via intramuscular route in the left deltoid as Immunization for Travel (Immunization) with no reported adverse event (expired product administered) following the administration of typhoid VI polysaccharide vaccine. Treatment: No This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- YELLOW FEVER VACCINE; RABIES VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 3,0
- Geschlecht
- M
- Eingang
- 17.09.2022
- Impfdatum
- 07.09.2022
- Beginn
- 07.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
had an excursion and were administered to a patient with no reported adverse event; had an excursion and were administered to a patient with no reported adverse event; Initial information received on 08-Sep-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 3 years old male patient who were administered vaccine post excursion with no reported adverse event , after receiving vaccine TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 07-Sep-2022, the patient received a dose of suspect TYPHOID VI POLYSACCHARIDE VACCINE (lot U2A471M and expiration date: 02-Nov-2023) at a dose of 0.5ml total dose via intramuscular route in the left arm for vaccination. On 07-Sep-2022, the patient developed a non-serious had an excursion and were administered to a patient with no reported adverse event (poor quality product administered)(latency: same day) (product storage error). Action taken :not applicable. It was not reported if the patient received a corrective treatment for the events. Outcome: unknown for both events This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 09.08.2022
- Impfdatum
- 08.08.2022
- Beginn
- 08.08.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Symptomtext
Yellow Fever (YF-Vax) administered IM in Right Deltoid. Patient monitored for 15 minutes post vaccination. No adverse side effects or outcome experienced by patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- H/o Anemia, Anxiety
- Andere Medikamente
- Lutera 0/1/20mg-mcg
- Allergien
- Eye drops, cough/cold medicine (generic)
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 29.07.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product storage error
Symptomtext
The Covid Vaccine (Gray top) Pfizer given to patient was outside of the 12 hour at room temperature recommendation for vaccine. No symptoms, side effects, or other concerns at this time. Spoke with the Pfizer Safety team. Staff states that a punctured vial of the Covid vaccine gray top should not exceed 36 hours at room temp range of 46 - 84 F. Vaccine was given from the vial that was at 26 hours at room temp of 70 F.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- None Known
- Andere Medikamente
- None
- Allergien
- None Known
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 12,0
- Geschlecht
- M
- Eingang
- 29.07.2022
- Impfdatum
- 29.07.2022
- Beginn
- 29.07.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Product storage error
Symptomtext
The Covid Vaccine (Gray top) Pfizer given to patient was outside of the 12 hour at room temperature recommendation for vaccine. No symptoms, side effects, or other concerns at this time. Spoke with the Pfizer Safety team. Staff states that a punctured vial of the Covid vaccine gray top should not exceed 36 hours at room temp range of 46 - 84 F. Vaccine was given from the vial that was at 26 hours at room temp of 70 F.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None known
- Vorgeschichte
- None known
- Andere Medikamente
- The Covid Vaccine (Gray top) Pfizer given to patient was outside of the 12 hour at room temperature recommendation for vaccine. No symptoms, side effects or other concerns at this time. Spoke with the Pfizer Safety team. Staff states that a
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 2,0
- Geschlecht
- M
- Eingang
- 30.06.2022
- Impfdatum
- 30.06.2022
- Beginn
- 30.06.2022
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Syringe issue
Symptomtext
When administering the vaccine, the patient moved his leg slightly and some of the vaccine dripped out. It is unknown how much came out or how much of the full dose he received.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -